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ABSTRACT Natural killer (NK) cells play a protective role against dengue virus (DENV)
infection, but the cellular and molecular mechanisms are not fully understood. Using
an optimized humanized mouse model, we show that human NK cells, through the
secretion of gamma interferon (IFN-), are critical in the early defense against DENV
infection. Depletion of NK cells or neutralization of IFN- leads to increased viremia
and more severe thrombocytopenia and liver damage in humanized mice. In vitro
studies using autologous human NK cells show that DENV-infected monocyte-
derived dendritic cells (MDDCs), but not monocytes, activate NK cells in a contact-
dependent manner, resulting in upregulation of CD69 and CD25 and secretion of
IFN-. Blocking adhesion molecules (LFA-1, DNAM-1, CD2, and 24) on NK cells abol-
ishes NK cell activation, IFN- secretion, and the control of DENV replication. NK cells
activated by infected MDDCs also inhibit DENV infection in monocytes. These ﬁnd-
ings show the essential role of human NK cells in protection against acute DENV in-
fection in vivo, identify adhesion molecules and dendritic cells required for NK cell
activation, and delineate the sequence of events for NK cell activation and protec-
tion against DENV infection.
IMPORTANCE Dengue is a mosquito-transmitted viral disease with a range of
symptoms, from mild fever to life-threatening dengue hemorrhagic fever. The di-
verse disease manifestation is thought to result from a complex interplay between
viral and host factors. Using mice engrafted with a human immune system, we show
that human NK cells inhibit virus infection through secretion of the cytokine gamma
interferon and reduce disease pathogenesis, including depletion of platelets and
liver damage. During a natural infection, DENV initially infects dendritic cells in the
skin. We ﬁnd that NK cells interact with infected dendritic cells through physical
contact mediated by adhesion molecules and become activated before they can
control virus infection. These results show a critical role of human NK cells in con-
trolling DENV infection in vivo and reveal the sequence of molecular and cellular
events that activate NK cells to control dengue virus infection.
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Dengue virus (DENV) infection is the most important arthropod-borne human viraldisease worldwide. An estimated 390 million infections occur each year, of which
500,000 cases develop severe dengue and 20,000 die (1). DENV is a single-stranded RNA
virus with four serotypes (DENV-1 to -4). Infection by any DENV serotype induces a
spectrum of disease manifestations that range from nonspeciﬁc febrile illness to
life-threatening dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS). Multi-
ple factors inﬂuence clinical outcomes, one of which appears to be a robust early host
response to DENV infection that prevents the development of severe disease (2, 3).
Natural killer (NK) cells are a critical component of the innate immune system and
provide early defense against viral infections (4, 5). Clinical and experimental studies
have suggested a protective role of NK cells during the early stages of DENV infection
(6–11). In adult patients, it was observed that mild dengue was correlated with higher
numbers of circulating activated NK cells displaying cytotoxic and adhesion molecule
proﬁles (6). Activated NK cells can inhibit viral infection through killing of virus-infected
cells and secretion of gamma interferon (IFN-). Increased IFN- levels have been
correlated with milder disease and higher survival rates in DHF patients (12, 13). In
mouse models, DENV infection of immunocompetent C57BL/6J mice leads to peak
IFN- production on day 5 postinfection, and NK cells represent the majority of cells
that stain positive for intracellular IFN- (9, 10). The cytotoxicity of NK cells against
DENV-infected cells was reported decades ago (14). NK cells also appear to play a key
role in antibody-dependent cell-mediated cytotoxicity (ADCC) against DENV-infected
cells during secondary infections when anti-DENV antibodies are present (15).
During a natural DENV infection by an infective mosquito, viral particles are intro-
duced into the subcutaneous space, where resident dendritic cells (DCs) are probably
the ﬁrst cell type to be infected (16). A subsequent local inﬂammatory response likely
recruits leukocytes, such as NK cells, to the site of infection. The migration of DENV-
infected DCs into draining lymph nodes leads to systemic dissemination of DENV and
infection of blood monocytes, which can become the dominant cell type infected by
DENV (17). Recently, using a coculture system of monocyte-derived dendritic cells
(MDDCs) and autologous human NK cells, it was reported that a combination of cell-cell
contact and the secretion of type I interferon and tumor necrosis factor alpha (TNF-)
by DENV-infected MDDCs (iMDDCs) was required for NK cell activation, secretion of
IFN-, and cytotoxicity toward iMDDCs (18). Despite these ﬁndings, how NK cells
become activated during DENV infection and what molecules are involved in NK cell
activation have not been fully elucidated.
By engrafting human CD34 hematopoietic stem/progenitor cells into immunode-
ﬁcient NOD-scid IL2rg/ (NSG) mice, it is possible to reconstitute the human immune
system in the recipient mice (19, 20). We have previously shown that these humanized
mice (humice) support robust DENV infection and subsequent pathogenesis, such as
transient leukopenia and thrombocytopenia exclusively of human platelets (19). We
have also shown that a single injection of plasmids encoding human interleukin 15
(IL-15) and Flt3 ligand (Flt3L) into humice dramatically increases the levels of human NK
cell reconstitution and function (20). In this study, we have generated NK cell-optimized
humice and shown that increased human NK cell reconstitution is associated with
elevated levels of human IFN- at early stages of infection and reduced viremia and
disease pathologies. Depletion of human NK cells or neutralization of IFN- abolishes
the protection against DENV infection. Furthermore, using DENV-infected human
monocytes and MDDCs, we show that NK cells are activated by DENV-infected MDDCs
but not monocytes. NK cell activation is contact dependent and requires the engage-
ment of adhesion molecules, such as LFA-1, DNAM-1, CD2, and 24. Taken collectively,
the results of our study identify cell types and molecules and delineate the sequential
events in NK cell activation and protection against DENV infection.
RESULTS
NK cells control acute dengue infection in humanized mice. To study human NK
cells in the control of acute DENV infection, we boosted the human NK cell levels in
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humanized mice by expressing human IL-15 and Flt3L through hydrodynamic injection
of cytokine-encoding plasmids (20). Seven days after plasmid injection, the levels of
human NK cells in the peripheral blood were increased from 2.7%  4.4% (n  8) in
uninjected humice to 8.6%  3.8% (n  8) in injected humice (Fig. 1A and B). The
elevated NK cell levels were maintained in plasmid-injected humice at 3 and 7 days
following DENV-2 infection. In contrast, NK T cell levels were not signiﬁcantly altered by
either the expression of IL-15 and Flt3L or dengue infection in either uninjected humice
(0.2%  0.1%, n  8) or injected humice (0.3%  0.2%, n  8). Humice injected with
cytokine plasmids are referred to as NK-optimized humice hereinafter, whereas humice
without cytokine plasmid injection are referred to control humice.
The effect of NK cells on DENV infection was determined by quantifying viral loads
in the serum by plaque assay. As shown by the results in Fig. 1C, the levels of viremia
increased from day 3 to day 7 following DENV-2 infection in both control and NK-
optimized humice. However, viremia was approximately 100-fold lower in NK-
optimized humice than in control humice both on day 3 and day 7 (P  0.0001). The
serum levels of human IFN- on day 3 postinfection were signiﬁcantly higher in
NK-optimized humice (310 92 pg/ml, n 10) than in control humice (50 52 pg/ml)
or mock-infected NK-optimized humice (38  51 pg/ml) (Fig. 1D). Of note, the serum
levels of human TNF- were similar in infected NK-optimized humice (51  58 pg/ml),
infected control humice (55  59 pg/ml), and mock-infected NK-optimized humice
(48  57 pg/ml) (Fig. 1E).
As commonly observed in dengue patients, DENV infection of humice leads to a
drop in human platelets in both control and NK-optimized humice (Fig. 2A); however,
the drop in human platelets in NK-optimized humice was less prominent than that in
control humice (95  8 platelets/l blood versus 25  3 platelets/l blood; P  0.05).
Consistent with a previous report (19), DENV infection in humice did not signiﬁcantly
FIG 1 NK cells play a critical role in the control of dengue virus infection in humice. Humice were injected
hydrodynamically with plasmids encoding the human cytokines IL-15 (50 g) and Flt3L (50 g). Seven days after
cytokine treatment, mice were infected with 1  107 PFU of DENV-2 by the intravenous route. (A) Representative
human CD3 versus CD56 staining proﬁles, obtained by gating on human CD45 cells before infection (day 0, i.e.,
7 days after hydrodynamic plasmid injection) and at 3 and 7 dpi. Numbers indicate percentages of cells in gated
regions. (B) Average percentages of CD3 CD56 NK cells among human CD45 cells in blood of DENV-infected
humice injected with IL-15 and Flt3L plasmids or PBS, determined at 0, 3, and 7 dpi. (C) Quantiﬁcation of humouse
viremia by plaque assay at 3 or 7 dpi. Each dot represents one humouse, numbers in parentheses indicate number
of humice per group, and horizontal bars show median values. (D and E) Serum levels of human IFN- (D) and
TNF- (E) quantiﬁed by ELISA. Error bars in bar graphs show standard errors of the means (SEM). *, P  0.05; ND,
not detectable.
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affect the levels of mouse platelets (Fig. 2B) or the overall hematocrit levels (data not
shown). Hepatic damage, as assessed by serum alanine aminotransferase (ALT) levels,
was signiﬁcantly lower in NK-optimized humice than in control humice at both day 3
and day 7 postinfection (Fig. 2C). Histopathological analysis conﬁrmed hepatic lesions
induced by DENV-2 infection, as indicated by the presence of inﬂammatory inﬁltrates
concentrated in the perivascular area spreading out into the liver parenchyma (Fig. 2D).
The inﬁltrates were composed predominantly of mononuclear cells, including macro-
phages and multinucleated giant cells. Hepatic lesions with ﬁbrous tissues and areas of
necrosis and hemorrhage in the parenchyma were observed. Hepatocyte edema and
degeneration were also evident in mice with severe lesions. The histopathological
scores in the DENV-2-infected humice were 4.9 1.8 out of a total of 20 points (Fig. 2E),
whereas the scores were only 1.8  1.2 points in infected NK-optimized humice. These
results show that an elevated level of human NK cells is associated with reduced
viremia and disease pathology in humice.
NK cells control dengue infection through IFN- production in humice. We
determined the requirement of NK cells and IFN- in the control of DENV infection by
depleting NK cells or neutralizing IFN- in NK-optimized humice. Humice were hydro-
dynamically injected with IL-15 and Flt3L plasmids (Fig. 3A). Six days later, the humice
were given anti-CD56 antibody, anti-IFN- antibody, or control antibody. They were
infected with DENV-2 on day 7 and given anti-CD56 antibody, anti-IFN- antibody, or
control antibody again on day 8. Three days after infection (day 10 after hydrodynamic
injection), humice were analyzed. With anti-CD56 antibody treatment, the levels of NK
cells in NK-optimized humice were reduced from 9.8%  2.7% to 3.8%  1.2% (Fig. 3B
and C), which was similar to the NK cell levels in control humice (3.7%  0.3%).
Anti-IFN- antibody treatment did not signiﬁcantly reduce the levels of NK cells in
FIG 2 Dengue disease is less severe in NK-optimized humice. NK-optimized humice (7 days after
hydrodynamic injection of plasmids) were infected with 1 107 PFU of DENV-2 by the intravenous route.
(A, B) Human and mouse platelet counts per microliter of blood of humice before infection (0) and at 3
and 7 dpi. (C) Serum levels of ALT in humice before infection and at 3 and 7 dpi. (D) Representative
hematoxylin and eosin (H&E) staining of liver sections of mock- and DENV-2-infected mice at 7 dpi. Scale
bar  100 m. (E) Semiquantitative analysis of hepatic damage based on H&E staining of liver sections
of mock- and DENV-2-infected mice at 7 dpi. *, P  0.05.
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FIG 3 IFN- production by human NK cells is essential to control DENV infection and disease manifestation in humice. (A) Scheme of
the experimental procedure. NK-optimized humice were injected with isotype, anti-human CD56, or anti-human IFN- antibody 1 day
(Continued on next page)
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NK-optimized humice (9.54%  2.5%). Compared to the levels of viremia in NK-
optimized humice, the levels in anti-CD56 antibody-treated NK-optimized mice were
increased to the same levels as in control humice (Fig. 3D). Similarly, neutralization of
IFN- also increased the viremia levels. Correspondingly, the serum IFN- levels were
signiﬁcantly reduced following both anti-CD56 and anti-IFN- antibody treatment in
NK-optimized humice (Fig. 3E). Greater decreases in human platelets (Fig. 3F), higher
levels of serum ALT (Fig. 3G), and more extensive liver damage (Fig. 3H and I) were
observed in anti-CD56 and anti-IFN- antibody-treated NK-optimized humice. In con-
trast, neutralizing human TNF- did not signiﬁcantly increase the viremia (data not
shown). These results show that NK cells play a critical role in controlling acute DENV
infection in humice, at least partly through the secretion of IFN-.
NK cells are activated by dengue virus-infected MDDCs. To elucidate the mech-
anism by which NK cells control DENV infection, we explored in vitro coculture
systems. We used dendritic cells as they are the ﬁrst innate immune cell type that
is naturally infected by DENV following a mosquito bite (21). Both NK cells and
monocytes were isolated from the same peripheral blood mononuclear cell (PBMC)
sample. Monocytes were cultured in the presence of IL-4 and granulocyte-
macrophage colony-stimulating factor (GM-CSF) for 7 days to generate MDDCs.
MDDCs were infected with DENV-2, and culture supernatants were harvested at 12,
24, 48, and 72 h to quantify virus titers and cytokine secretion. In four of ﬁve donors,
the virus titer reached the peak level 48 h following infection (see Fig. S1A in the
supplemental material). The levels of IFN-, IL-12p40, and TNF- in the superna-
tants were highest 48 h after infection (Fig. S2A to C), while the levels of IFN-
peaked at 24 h after infection and signiﬁcant levels remained at 48 h (Fig. S2D). To
conﬁrm the essential role of IFN- in controlling DENV infections, we added
recombinant IFN- to cultures of infected MDDCs. Indeed, exogenous IFN- com-
pletely inhibited DENV replication in infected MDDCs (Fig. S3).
We cocultured NK cells and autologous MDDCs at ratios of 1:1, 1:5, and 1:10. At a
ratio of 1:5, NK cells inhibited DENV-2 production by ~100-fold (Fig. 4A). The level of
IFN- in the culture supernatants was signiﬁcantly increased compared to the level in
supernatants from infected MDDCs (iMDDCs) only (Fig. 4B). Likewise, the level of TNF-
was also signiﬁcantly increased at a ratio of 1:5 (Fig. 4C). Activation markers like CD69
and CD25 were upregulated on NK cells after coculture for 48 h with infected MDDCs
compared to their levels on NK cells cocultured with uninfected MDDCs (Fig. 4D and E).
Consistent with the IFN- levels detected by enzyme-linked immunosorbent assay
(ELISA), the percentages of NK cells positive for intracellular IFN- were signiﬁcantly
increased following coculture with infected MDDCs compared with the percentages in
uninfected MDDCs (6.0%  0.9% versus 1.4%  0.6%, P  0.01) (Fig. 4F). Furthermore,
the ability of NK cells to control DENV infection was not restricted to the DENV-2
serotype. Coculture of naive NK cells with MDDCs infected with DENV-1, DENV-3, or
DENV-4 also resulted in an ~100-fold reduction in viral titer in the culture supernatants
(Fig. S4A) and elevated IFN- production (Fig. S4B). These results suggested that NK
cells are activated after coculture with DENV-infected MDDCs, leading to secretion of
IFN- and TNF-, which control replication in infected MDDCs.
Cell-cell contact is required for NK cell activation and control of DENV-2
infection in MDDCs. We determined whether cell-cell contact was required for NK cell
activation by infected MDDCs via a transwell system. NK cells were either cocultured
FIG 3 Legend (Continued)
before and 1 day after infection with 1  107 PFU DENV-2. Mice were sacriﬁced at 3 dpi. (B) Representative human CD3 versus CD56
staining proﬁles, obtained by gating on human CD45 cells at 3 dpi. The numbers indicate percentages of cells in the gated regions. (C)
Average percentages of CD3 CD56 NK cells within human CD45 cell populations in the blood of humice. (D) Quantiﬁcation of viremia
at 3 dpi, determined by plaque assay. Each dot represents one humouse, and numbers in parentheses indicate number of humice per
group. (E) Serum levels of human IFN- quantiﬁed by ELISA. (F) Human platelet counts per microliter of blood of humice. (G) ALT levels
in sera of humice. (H) Semiquantitative analysis of hepatic damage at 3 dpi. (I) Representative H&E stains of liver sections from each group
at 3 dpi. Scale bar  100 m. Error bars in bar graphs show standard errors of the means (SEM); horizontal bars in dot plot show median
values. *, P  0.05.
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with infected autologous MDDCs in the same chamber or separated by a 0.4-m
membrane in a different chamber where NK cells did not have direct contact with
infected MDDCs (Fig. 5A). As expected, the virus titers in the supernatants were reduced
by ~100-fold when NK cells were cocultured with infected MDDCs compared to the
titers in infected MDDCs alone (Fig. 5B). The reduction of virus titers was mostly
abolished when NK cells were placed in the transwell. Consistently, NK cells were
activated to express much higher levels of CD69 and IFN- (Fig. 5C to E) when they
were cocultured with infected MDDCs in the same chamber. Although CD69 was also
upregulated on NK cells when they were cocultured with infected MDDCs in transwells,
the level of upregulation was much lower. Thus, direct cell-cell contact between NK
cells and infected MDDCs is a critical ﬁrst step in which NK cells become activated to
secrete IFN- and control DENV infection.
Adhesion molecules are required for interactions between NK cells and in-
fected MDDCs. Given the requirement for direct cell-cell contact in NK cell activation
and control of dengue infection, we examined the involvement of speciﬁc NK cell
surface molecules, including adhesion molecules (24, LFA-1, DNAM-1, and CD2) and
natural cytotoxicity-triggering receptors (NKp30, NKp44, NKp46, and NKG2D). NK cells
expressed the various adhesion molecules, but their levels of expression were not
FIG 4 Naive NK cells are activated by infected MDDCs in vitro. MDDCs were infected with DENV-2 (MOI
of 1) for 2 h and then incubated with autologous puriﬁed human NK cells for 48 h. (A to C) To determine
the optimal MDDC/NK cell coculture ratio, infected MDDCs (iMDDCs) were cocultured with various
numbers of NK cells. (A) Viral titers in culture supernatants as quantiﬁed by plaque assay. (B, C) IFN- (B)
and TNF- (C) levels in culture supernatants, quantiﬁed by ELISA. (D to F) Naive NK cells are activated
after incubation with iMDDCs at a ratio of 1:5. (D) Representative CD56 versus CD69 staining proﬁles
(right) and mean ﬂuorescence intensities (MFI) of CD69 (left) for NK cells cocultured with uninfected
MDDCs (NK  MDDC) or iMDDCs (NK  iMDDC). (E) Representative CD56 versus CD25 staining proﬁles
(right) and percentages of CD25-positive NK cells (left) in cocultures with uninfected MDDCs or iMDDCs.
(F) Representative CD56 versus IFN- staining proﬁles (right) and percentages of IFN--positive NK cells
(left) in cocultures with uninfected MDDCs or iMDDCs. Bar graphs show mean values  standard
deviations (SD). Numbers in ﬂow cytometry plots indicate CD69 MFI or percentages of CD25- or
IFN--positive cells in gated regions. Each dot in a dot plot represents a different donor, and horizontal
bars show median values. *, P  0.05.
DCs Drive NK Cell Activation during DENV Infection ®
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changed signiﬁcantly following coculture with infected MDDCs (Fig. S5). NK cells
expressed NKp46 and NKG2D but very little, if any, NKp44 and NKp30. The expression
of these receptors was not altered following coculture of NK cells with infected MDDCs
(Fig. S6).
To block each of these receptors, puriﬁed NK cells were incubated with receptor-
speciﬁc antibodies individually for 2 h and then cocultured with infected MDDCs for
48 h. NK cells were assayed for CD69 expression, and the culture supernatants for virus
titers and IFN-. As shown by the results in Fig. 6, blocking NKp46, NKp44, NKp30, and
NKG2D did not inhibit NK cell activation or reduce the virus titer; i.e., NK cells were
activated in the presence of these blocking antibodies as indicated by upregulation of
CD69 (Fig. 6A and B), reduction of virus titers by about 100-fold (Fig. 6C), and high levels
of IFN- in the culture supernatants (Fig. 6D). In contrast, blocking the adhesion
molecules CD2, DNAM-1, LFA-1, and 24 all resulted in inhibition of NK cell activation
(Fig. 6A and B), elevated virus titers (Fig. 6C), and diminished IFN- secretion (Fig. 6D).
Blocking all four adhesion molecules simultaneously did not result in an additive effect
on the reduction of viral titers (data not shown). These results show that adhesion
molecules but not speciﬁc natural cytotoxicity receptors are required for NK cell
interaction with infected MDDCs, consistent with a requirement for cell-cell contact for
NK cell activation, IFN- secretion, and control of DENV infection.
Activated NK cells also control DENV infection in human monocytes.Monocytes
and macrophages can also be infected by DENV (17). We also tested whether
infected monocytes can activate NK cells. Both NK cells and monocytes were
puriﬁed from human PBMC. NK cells were cocultured with autologous DENV-
infected monocytes at a multiplicity of infection (MOI) of 10 for 48 h, and NK cell
activation, IFN- secretion, and virus titers were assayed. As shown by the results in
Fig. 7, NK cells did not upregulate CD69, reduce viral titers in the culture superna-
tants, or secrete IFN-. In contrast, if NK cells were activated with IL-2 (22, 23) prior
to their addition into the coculture with infected monocytes, the virus titers were
reduced by about 100-fold concomitant with a signiﬁcant level of IFN- being
found in the culture supernatants.
During a natural DENV infection in humans, dendritic cells in the skin are infected
ﬁrst, followed by infection of monocytes and macrophages in the peripheral blood. We
FIG 5 Cell-cell contact is required for efﬁcient control of DENV infection of MDDCs in vitro. (A) Scheme
of the transwell experiment setup. (B) Viral titers in the culture supernatants at 48 h of infection. (C) IFN-
levels in the culture supernatants at 48 h of infection. (D) Representative CD56 versus CD69 staining
proﬁles of NK cells at 48 h of infection. Numbers indicate MFI. (E) MFI of CD69 on NK cells in three
cocultures at 48 h of infection. Bar graph shows mean values  SD. Each dot in a dot plot represents a
different donor, and horizontal bars show median values. *, P  0.05.
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investigated whether NK cells activated by infected MDDCs could control DENV infec-
tion in human monocytes. NK cells were cocultured with infected MDDCs for 48 h,
puriﬁed by cell sorting, and cultured with DENV-infected autologous monocytes at a
ratio of 1:5 for another 48 h. As with IL-2-activated NK cells, iMDDC-activated NK cells
upregulated CD69 expression (Fig. 7A and B), reduced the virus titers by 10-fold,
compared to 100-fold by IL-2-activated NK cells (Fig. 7C), and secreted IFN- (Fig. 7D).
Similar to what we observed in NK cell-MDDC coculture, cell-cell contact (Fig. S7) and
adhesion molecules (Fig. S8) were required for the reduction of viral titers and IFN-
secretion by NK cells cocultured with DENV-infected monocytes. Thus, NK cells are not
activated directly by DENV-infected monocytes, but if NK cells are ﬁrst activated by
DENV-infected MDDCs, they can control DENV infection in monocytes.
DISCUSSION
In this study, we have examined the role of human NK cells in the control of DENV
infection in vivo (NK-optimized humice) and the cellular and molecular events required
for NK cell activation and IFN- secretion. Although studies have suggested an impor-
tant role of NK cells and IFN- in protection against DENV infection, previous studies
were carried out either in vitro using puriﬁed NK cells due to the lack of a small animal
model of dengue infection (6, 7, 24) or through correlative studies in patients (6). We
have taken advantage of NK-optimized humice that support robust DENV infection. By
modulating the level of human NK cells or IFN- in humice and examining the effects
on viremia and disease pathologies, our results conﬁrmed an essential role played by
human NK cells and IFN- in the control of DENV infection in vivo. Our study speciﬁcally
FIG 6 Adhesion molecules on NK cell surface are involved in NK cell-MDDC interactions. Human monocytes were puriﬁed by negative selection,
and monocyte-derived dendritic cells (MDDCs) were generated in vitro by adding IL-4 and GM-CSF for 7 days. Autologous NK cells were puriﬁed
by negative selection. MDDCs were infected with DENV-2 (MOI of 1) for 2 h and then incubated with puriﬁed autologous NK cells for 48 h in the
presence or absence of anti-NK cell receptor antibodies. (A) Shown are representative CD69 versus CD56 staining proﬁles in the presence or
absence of blocking antibody. (B) Mean ﬂuorescence intensities (MFI) of CD69 on NK cells in coculture with iMDDCs in the presence or absence
of blocking antibody. (C) Viral loads in culture supernatants after 48 h, determined by plaque assay. (D) IFN- levels in culture supernatants after
48 h, determined by ELISA. Each dot in a dot plot represents a different donor, and horizontal lines show median values. Bar graph shows mean
values  SD. ND, not detectable; ns, not statistically signiﬁcant; *, P  0.05.
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shows that the NK cell response to DENV infection in humice is primarily mediated by
secretion of IFN-.
More importantly, we have identiﬁed molecules required for NK cell activation and
IFN- secretion. We showed that cell-cell contact between infected MDDCs and NK cells
is critical for NK cell activation and IFN- secretion. By blocking speciﬁc NK cell
receptors, we identiﬁed adhesion molecules, including CD2, 24, LFA-1, and DNAM-1,
on NK cells, but not NK cell activation receptors, as required for mediating the cell-cell
contact and NK cell activation. Interestingly, DENV infection did not change the
expression of the ligands of these receptors, including CD58, CD48, ICAM-1, and CD155,
on infected MDDCs (data not shown), consistent with a similar report by Lim et al. (18).
In addition, blocking any of these four adhesion molecules almost completely abol-
ished NK cell activation and IFN- expression, whereas blocking all four simultaneously
did not show any additive effect, suggesting cooperative engagement of these adhe-
sion molecules in NK activation and IFN- secretion. We have shown previously that the
activation of NK cells by Plasmodium falciparum-infected red blood cells also requires
adhesion molecules LFA-1 and DNAM-1, but not CD2 and 2B4, in a contact-dependent
manner (25). These ﬁndings suggest a general mechanism of cell-cell contact involving
adhesion molecules in pathogen-mediated NK cell activation, but the speciﬁc adhesion
molecules involved may differ with different pathogens.
In contrast to the case for adhesion molecules, blocking NKp44, NKp46, NKp30, and
NKG2D did not have any effect on NK cell activation and IFN- secretion and control of
DENV infection. The levels of NKp44 and NKp30 on NK cells are minimal, and this could
explain the absence of any effect. Both NKG2D and NKp46 are expressed by NK cells.
In fact, genome-wide associated studies have identiﬁed MICA and MICB, which are
ligands for NKG2D, as susceptibility loci for dengue shock syndrome (26, 27). However,
blocking NKG2D has no effect on the NK cell response to DENV2-infected MDDCs or
monocytes. A similar observation has also been reported with human cytomega-
lovirus (HCMV) infection, where inhibition of surface expression of ULBPs, a class of
NKG2D ligands, did not affect NK cell activation, suggesting the presence of
NKG2D-independent pathways (28).
Our results are consistent with previous ﬁndings showing a critical role of IFN- in
FIG 7 Activated NK cells also control DENV infection in human monocytes. Human NK cells and
monocytes (MO) were puriﬁed from PBMC by negative selection. NK cells were activated by culturing
with either IL-2 for 5 days or iMDDCs for 48 h. Activated NK cells from iMDDC culture were puriﬁed by
negative selection. Puriﬁed monocytes were infected with DENV-2 at an MOI of 10 for 2 h (iMO) and then
cocultured with naive, IL-2-activated, or iMDDC-activated autologous NK cells for 48 h. NK cells were
assayed for CD69 expression, and culture supernatants were assayed for viral titers and IFN-. (A)
Representative CD56 versus CD69 staining proﬁles, obtained by gating on CD1a-negative cells from the
four different cocultures. The numbers indicate CD69 MFI. (B) CD69 MFI of NK cells in the four cocultures.
(C) Viral titers in the four culture supernatants. (D) IFN- levels in the four culture supernatants. Each dot
in the dot plots represents a different donor, and horizontal bars show median values. Bar graph shows
mean values  SD. *, P  0.05; ND, not detectable; ns, not statistically signiﬁcant.
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NK cell-mediated antiviral responses. When NK cells were cocultured with DENV-
infected MDDCs, secretion of both IFN- and TNF- was induced. However, DENV
infection of humanized mice induced IFN- but not TNF- in the circulation. Further-
more, neutralizing IFN- but not TNF- in humanized mice abolished the NK cell
response to DENV, suggesting that IFN- but not TNF- is required for NK cell control
of DENV infection in vivo. Lim et al. have reported that the combination of cell-cell
contact and type I interferon and TNF- is required for activating NK cell cytotoxicity
(18). However, a closer examination of their data revealed that cell-cell contact con-
tributes nearly 90% to NK cell activation. Consistent with this, the results from our
transwell study show that cell-cell contact plays a dominant role in NK cell activation,
whereas the effect of soluble factors is minimal.
Our study also shed light on the possible sequence of events that leads to NK cell
activation and control of DENV infection in vivo. During a natural dengue infection,
resident DCs in the skin are the ﬁrst cell type to be infected (16). Migration of infected
DCs into the draining lymph nodes is thought to spread the infection systemically,
leading to infection of monocytes in the circulation (17). It is notable that infected
MDDCs, but not monocytes, activate NK cells and IFN- secretion, suggesting that NK
cells are likely activated at a very early stage of DENV infection. Following the infection
of DCs, the ensuing inﬂammatory response recruits leukocytes, such as NK cells, into
the site of infection. NK cells could be activated at the site of the mosquito bite or in
the draining lymph nodes. Activated NK cells and their secreted IFN- then control
infection of DCs, as well as monocytes. It would be interesting to elucidate the
molecular basis underlying the difference by which infected MDDCs but not monocytes
activate NK cells.
MATERIALS AND METHODS
Ethics statement. This study was carried out in strict accordance with the ethical and animal
experiment regulations of the National Advisory Committee for Laboratory Animal Research (NACLAR)
(29). The experimental protocol was approved by the Institutional Animal Care and Use Committee
(IACUC) of the National University of Singapore (NUS) and Massachusetts Institute of Technology (MIT)
under access number R13-6157. All surgeries were performed under 5% isoﬂurane anesthesia, and all
efforts were made to minimize animal suffering. Studies with DENV were conducted under biosafety level
2 (BSL2) containment at the National University of Singapore animal facility. Human CD34 hematopoi-
etic stem/progenitor cells were puriﬁed from fetal liver by CD34 magnetic selection (Stem Cell
Technologies). All women were informed of the risks of participation in the study, and a written consent
for fetal tissue donation to research was obtained from each woman. SingHealth and National Health
Care Group Research Ethics Committees Singapore speciﬁcally approved this study (CIRB reference
number 2012/064/B).
Generation of humice and NK-optimized humice. Nod-Scid-IL-2Rnull (NSG) mice were purchased
from Jackson Laboratories (Bar Harbor, ME) and maintained under pathogen-free conditions in National
University of Singapore animal facilities. To generate humice, 2  105 human CD34 cells were injected
intracardially into each sublethally irradiated NSG pup within 24 to 48 h of birth as previously described
(20). At 10 to 12 weeks, humice were assessed for human leukocyte reconstitution. Those with more than
40% human leukocyte reconstitution in the peripheral blood mononuclear cells (PBMC) were further
injected hydrodynamically with plasmids encoding human IL-15 (50 g) and Flt3L (50 g) to generate
NK-optimized humice. Anti-human CD56 (HCD56), anti-human IFN-, and anti-human TNF- antibodies
were injected intravenously at 50 g/mouse to deplete human NK cells or neutralize human IFN- and
human TNF-, respectively, 24 h before and 24 h after dengue infection (25). To assess for NK cell
depletion, anti-human CD56 antibody (MEM188), which recognizes a different epitope from anti-human
CD56 antibody (HCD56), was used.
Production of viruses and plaque assay. DENV-2 (Eden-07K2861), DENV-1 (Eden-2402DK1), DENV-3
(Eden-863DK1), and DENV-4 (Eden-2270DK1) strains were propagated in mosquito cells (Aedes albopictus
clone C6/36 [ATCC CRL-1660, existing collection in our laboratory]) in RPMI 1640 medium (Gibco)
with 10% fetal bovine serum (FBS) (Lonza) at 28°C. To concentrate the virus, 50 ml of the cell culture
supernatant was loaded onto a VivaCell 100 centrifugal concentrator (Sartorius) and centrifuged at
2,000  g for 10 min, and the supernatant remaining in the concentrator was aliquoted and stored
at 80°C. For quantiﬁcation of virus, BHK-21 cells (C-13) (ATCC CCL-10; originally from ATCC, existing
collection in our laboratory) were grown to a conﬂuent monolayer in RPMI 1640 medium with 10%
FBS (Lonza) and 1% penicillin-streptomycin-glutamine (Gibco) in 24-well plates at 37°C. The virus
was serially diluted in serum-free medium and then inoculated into the cells at 37°C with gentle
shaking every 15 min for 1 h. Next, the medium was replaced with RPMI 1640 medium containing
2% carboxymethylcellulose (CMC) and 2% FBS (Lonza) (overlay medium) and the culture kept at
37°C. After 5 days, the cells were ﬁxed in 3% formalin in phosphate-buffered saline (PBS) for 1 h,
washed, and stained with 0.1% crystal violet in 10% formalin solution for 1 h. Then, the plates were
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washed with water, and the plaques were counted. One PFU of the cell culture supernatant was
observed to have close to 1,000 copies of viral RNA.
Infection of humanized mice. Humanized mice were infected by injecting 1  107 PFU of the
concentrated DENV-2 virus in 200 l of RPMI 1640 medium through the tail vein. Control humanized
mice reconstituted with the same batch of human CD34 fetal liver cells were injected with 200 l of
plain RPMI 1640 medium. In some experiments, virus was heat inactivated (at 60°C for 1 h) and then
injected into the humanized mice as the control. Blood, liver, spleen, lymph node (axillary), and bone
marrow (femur) were collected from control and infected mice at different days postinfection (dpi) for
ﬂow cytometry assays, viral RNA quantiﬁcation, alanine aminotransferase (ALT) assays, platelet counts,
and histology.
ALT measurement and histopathological analysis. ALT levels in the sera from mice at 7 dpi were
measured using a Cobas C111 analyzer (Roche) in the NUS comparative medicine in-house veterinary
diagnostic laboratory. Histopathological analysis was performed as previously described by Costa et al.
(10). Brieﬂy, liver samples from humice were obtained at day 7 after DENV-2 inoculation. Afterward,
samples were immediately ﬁxed in 10% buffered formalin for 24 h and embedded in parafﬁn. Tissue
sections (4 mm thick) were stained with hematoxylin and eosin (H&E) and evaluated under an Axioskop
40 microscope (Carl Zeiss, Göttingen, Germany) adapted to a digital camera (PowerShot A620; Canon,
Tokyo, Japan). Histopathology scoring was carried out by a pathologist in a blinded fashion according to
a set of custom-designed criteria described by Costa et al. (10). Hepatocyte swelling, degenerative
changes, necrosis, and hemorrhage were each graded on a scale of 0 to 5 (0, absent; 1, minimal; 2, slight;
3, moderate; 4, marked; and 5, severe). The sum of the score was computed to derive the overall liver
damage score. A total of two sections for each animal were examined.
NK cell and MDDC/monocyte coculture system. Monocytes were negatively selected from total
PBMC using the EasySep human monocyte enrichment kit without CD16 depletion (Stemcell Technol-
ogies). To generate MDDCs, monocytes were cultured for 7 days in RPMI 1640 (Sigma) supplemented
with 10% FBS (Gibco), IL-4 (500 U/ml; PeproTech), and GM-CSF (500 U/ml; PeproTech). The MDDC
phenotype was veriﬁed by ﬂow cytometry as CD1a CD209 CD14 CD83/low. Infection of MDDCs by
DENV-2 virus was performed at an MOI of 1 in RPMI medium (RPMI supplemented with 3% FBS) for 2 h,
followed by 3 washes to remove free virus. Autologous NK cells were puriﬁed from PBMC using the
EasySep human NK cell enrichment kit (Stemcell Technologies) and cocultured with infected or unin-
fected MDDCs at ratios of 1:1, 1:5, and 1:10 in RPMI medium.
Alternatively, monocytes were infected with DENV (MOI of 10) in RPMI medium (RPMI supple-
mented with 3% FBS) for 2 h, followed by 3 washes to remove free viruses. A higher MOI was used
for monocyte infection than for MDDC infection because monocytes are more resistant to DENV
infection. Autologous NK cells were cocultured with infected or uninfected monocytes at ratios of
1:1, 1:5, and 1:10 in RPMI medium. For transwell experiments, culture plates with a 0.4-m
membrane from Millipore were used. For receptor blocking experiments, the following neutralizing
antibodies (BioLegend) were used at 1 l/ml: anti-CD11a (HI111), anti-CD18 (TS1/18), anti-CD2
(TS1/8), anti-DNAM (11A8), anti-2B4 (C1.7), anti-NKp46 (9E2), anti-NKp30 (P30-15), anti-NKp44
(P44-8), and anti-NKG2D (1D11) antibodies.
Measurement of cytokine/chemokine concentrations. The concentrations of cytokines (TNF-,
IFN-, IFN-, IL-12p40, and IL-18) in serum samples or culture supernatants were measured using
commercially available antibodies and according to the procedures supplied by the manufacturer (R&D
Systems, Minneapolis, MN). The results are expressed as picograms per milliliter. The detection limits of
the ELISA assays were in the range of 4 to 8 pg/ml.
Flow cytometry. Antibodies speciﬁc for human CD45 (2D1), CD14 (HCD14), CD56 (HCD56), CD56
(MEM188), CD19 (HIB19), CD3 (HIT3a), CD69 (FN50), and CD25 (FN50) and for mouse CD45.1 (A20) were
obtained from BioLegend. Cells were stained with appropriate antibodies in 50 l of ﬂuorescence-
activated cell sorting (FACS) buffer (PBS with 0.2% bovine serum albumin [BSA] and 0.05% sodium azide)
for 30 min on ice. Stained cells were analyzed by ﬂow cytometry using an LSRII instrument, and data were
analyzed by using FACSDiva (BD Biosciences) or FlowJo (TreeStar, Inc.).
Mouse and human platelets were evaluated as previously described by Sridharan et al. (19). Brieﬂy,
10 l of whole blood was resuspended in 600 l of FACS buffer. Antibodies speciﬁc for human CD41 and
mouse CD41 were added and incubated for 10 min. Then, 25 l of CountBright absolute counting beads
(Invitrogen) was added to each sample and analyzed until 1,000 beads were recorded per sample. The
number of human or mouse platelets was calculated as follows: count of platelets/l of whole blood 
(target platelet events/bead events)  (bead count/10 l).
Statistical analysis. For numerical continuous data, such as mean ﬂuorescence intensities (MFI), cell
percentages, DENV viremia, cytokine concentrations, liver enzymes, and platelet counts, the unpaired
t test was used to determine whether the means of the two samples were signiﬁcantly different. For
ranked data, such as the histological scoring of liver damage, the Mann-Whitney test was used to
determine whether the scores were signiﬁcantly different. Statistical analysis was performed using
GraphPad Prism (GraphPad Software, Inc.).
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/mBio
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